Stylissatin A, a cyclic peptide that inhibits nitric oxide production from the marine sponge Stylissa massa

Tetrahedron Letters

Volumn 54, Issue 50, 2013, Pages 6826-6828

  Kita, Masaki ^a   Gise, Baro ^a   Kawamura, Atsushi ^a   Kigoshi, Hideo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cyclic peptide; Inhibition of nitric oxide production; Isolation and structure; Natural products

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPEPTIDE; DICHLOROMETHANE; ISOLEUCINE; LIPOPOLYSACCHARIDE; METHANOL; NITRIC OXIDE; PHENYLALANINE; PROLINE; STYLISSATIN A; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC50; MARINE SPECIES; MASS SPECTROMETRY; MOUSE; NONHUMAN; PHASE SEPARATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAW 264.7 CELL LINE; SPONGE (PORIFERA); STYLISSA MASSA;

EID: 84922139924     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2013.10.003     Document Type: Article

References (20)

1. Bames, P.J., Larin, M., New Engl. J. Med. 336 (1997), 1066–1071.
2. Nathan, C., FASEB J. 6 (1992), 3051–3064.
3. Bredt, D. S.; Snyder, S. H. Ann. Rev. Biochem. 1994, 63, 175–195.
4. Bogdan, C., Nat. Immunol. 2 (2001), 907–916.
5. Droge, W., Physiol. Rev. 82 (2002), 47–95.
6. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J., Int. J. Biochem. Cell Biol. 39 (2007), 44–84.
7. 50 = 245 μM).
8. 13C NMR, see Table 1.
9. Marfey, P., Carlsberg Res. Commun. 49 (1984), 591–596.
10. Dinitrophenyl-l-alanine amide derivatives were analyzed by the reverse-phase HPLC [Deverosil ODS-HG-5 (φ 4.6 x 250 mm), 1 mL/min, 30–40% aq. MeCN with 0.1% TFA (linear gradient for 60 min), 25°C, UV 340 nm]. Retention times of the authentic samples: l-Pro, 15.9 min; d-Pro, 22.0 min; l-Tyr, 20.0 min; d-Tyr, 23.6 min; l-Ile, 40.4 min; d-Ile, 55.5 min; l-Phe, 45.6 min; d-Phe, 61.5 min. Retention times of the samples from the hydrolysate: l-Pro, 15.6 min; l-Tyr, 20.4 min; l-Ile, 40.4 min; l-Phe, 45.7 min, and no d-amino acid derivative peaks were detected.
11. Cerny, R.L., Gross, M.L., Tandem mass spectrometry for determining the amino acid sequences of cyclic peptides and for assessing interactions of peptides and metal ions. Desiderio, D.M., (eds.) Mass Spectrometry of Peptides, 1991, CRC Press, Boca Raton, FL, 289–314.
12. Pettit, G.R., Gao, F., Cerny, R.L., Doubek, D.L., Tackett, L.P., Schmidt, J.M., Chapuis, J.C.J., Med. Chem. 37 (1994), 1165–1168.
13. 3OD.
14. For example, (a) Renner, M. K.; Shen, Y.; Cheng, X.; Jensen, P. R.; Frankmoelle, W.; Kauffman, C. A.; Fenical, W.; Lobkovsky, E.; Clardy, J. J. Am. Chem. Soc. 1999, 121, 11273–11276; (b) Randazzo, A.; Bifulco, G.; Giannini, C.; Bucci, M.; Debitus, C.; Cirino, G.; Gomez–Paloma, L. J. Am. Chem. Soc. 2001, 123, 10870–10876; (c) Gonzalez–Rey, E.; Varela, N.; Sheibanie, A. F.; Chorny, A.; Ganea, D.; Delgado, M. Proc. Natl. Acad. Sci. USA 2006, 103, 4228–4233.
15. For example, (a) Trischman, J. A.; Tapiolas, D. M.; Jensen, P. R.; Dwight, R.; Fenical, W.; McKee, T. C.; Ireland, C. M.; Stout, T. J.; Clardy, J. J. Am. Chem. Soc. 1994, 116, 757–758; (b) Moore, B. S.; Trischman, J. A.; Seng, D.; Kho, D.; Jensen, P. R.; Fenical, W. J. Org. Chem. 1999, 64, 1145–1150; (d) Li, D.; Carr, G.; Zhang, Y.; Williams, D. E.; Amlani, A.; Bottriell, H.; Mui, A. L. -F.; Andersen, R. J. J. Nat. Prod. 2011, 74, 1093–1099.
16. Dellai, A., Maricic, I., Kumar, V., Arutyunyan, S., Bouraoui, A., Nefzi, A., Bioorg. Med. Chem. Lett. 20 (2010), 5653–5657.
17. Yang, Y., Hua, K., Chuang, P., Wu, S., Wu, K., Chang, F., Wu, Y.J., Agric. Food Chem. 56 (2008), 386–392.
18. Vanderslice, P., Ren, K., Revelle, J.K., Kim, D.C., Scott, D., Bjercke, R.J., Yeh, E.T., Beck, P.J., Kogan, T.P.J., Immunol. 158 (1997), 1710–1718.
19. Lina, K., Castrob, A.C., Curr. Opin. Chem. Biol. 2 (1998), 453–457.
20. For example, (a) Kobayashi, J.; Tsuda, M.; Nakamura, T.; Mikami, Y.; Shigemori, H., Tetrahedron 1993, 49, 2391–2402; (b) Morita, H.; Yun, Y. S.; Takeya, K.; Itokawa, H. Tetrahedron Lett. 1994, 35, 9593–9596; (c) Morita, H.; Gonda, A.; Takeya, K.; Itokawa, H.; Shirota, O. Chem. Pharm. Bull. 1997, 45, 161–164; (d) Tabudravu, J.; Morris, L. A.; Kettenes-van den Bosch, J. J.; Jaspars, M. Tetrahedron Lett. 2001, 42, 9273–9276; (e) Tabudravu, J. N.; Morris, L. A.; Kettenes-van den Bosch, J. J.; Jaspars, M. Tetrahedron 2002, 58, 7863–7868; (f) Brennan, M. R.; Costello, C. E.; Maleknia, S. D.; Pettit, G. R.; Erickson, K. L. J. Nat. Prod. 2008, 71, 453–456, and references are therein; (g) Arai, M.; Yamano, Y.; Fujita, M.; Setiawan, A.; Kobayashi, M. Bioorg. Med. Chem. Lett. 2012, 22, 1818–1821.